NSC |
Compound |
Enrichment |
Correlation |
NSC 671891 |
Null |
0.024789837445214 |
-0.34690695 |
NSC 680553 |
2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester |
0.024789837445214 |
0.68565213 |
NSC 685685 |
3-Pyridinecarboxylic acid, 4-[2-cyano-2-(ethoxycarbonyl)-1- (2-phenyhydrazino)ethenyl]- |
0.024789837445214 |
-0.51104516 |
NSC 709341 |
Null |
0.024789837445214 |
-0.3489351 |
NSC 749117 |
3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline |
0.0248868750898605 |
-0.19929856 |
NSC 753218 |
3-hydroxy-5,6-dihydro-6-imino-9-methoxyisoindolo-[2,1-a]quinoxaline |
0.0248868750898605 |
-0.12663627 |
NSC 754081 |
7-(4-methoxybenzyl)-4,4-dimethyl-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole |
0.0248868750898605 |
-0.28493612 |
NSC 754109 |
ethyl 8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate |
0.0248868750898605 |
-0.32440845 |
NSC 756134 |
GSK1023156A |
0.0248868750898605 |
-0.22313844 |
NSC 756233 |
GW435821X |
0.0248868750898605 |
-0.089515869 |